Literature DB >> 15477093

Production and purification of Bacillus anthracis protective antigen from Escherichia coli.

Michael W Laird1, David Zukauskas, Kelly Johnson, Gavin C Sampey, Henrik Olsen, Andy Garcia, Jeffrey D Karwoski, Bridget A Cooksey, Gil H Choi, Janine Askins, Amos Tsai, Jennifer Pierre, William Gwinn.   

Abstract

Anthrax is caused by the gram-positive, spore-forming bacterium, Bacillus anthracis. The anthrax toxin consists of three proteins, protective antigen (PA), lethal factor, and edema factor. Current vaccines against anthrax use PA as their primary component since it confers protective immunity. In this work, we expressed soluble, recombinant PA in relatively high amounts in the periplasm of E. coli from shake flasks and bioreactors. The PA protein was purified using Q-Sepharose-HP and hydroxyapatite chromatography, and routinely found to be 96-98% pure. Yields of purified PA varied depending on the method of production; however, medium cell density fermentations resulted in approximately 370 mg/L of highly pure biologically active PA protein. These results exhibit the ability to generate gram quantities of PA from E. coli.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15477093     DOI: 10.1016/j.pep.2004.08.007

Source DB:  PubMed          Journal:  Protein Expr Purif        ISSN: 1046-5928            Impact factor:   1.650


  12 in total

1.  In vitro and in vivo activities of recombinant anthrax protective antigen co-expressed with thioredoxin in Escherichia coli.

Authors:  Yao Ma; Yun-Zhou Yu; Yu-Feng Zhu; Qing Xu; Zhi-Wei Sun
Journal:  Hum Vaccin Immunother       Date:  2013-07-23       Impact factor: 3.452

2.  Bacillus anthracis edema but not lethal toxin challenge in rats is associated with depressed myocardial function in hearts isolated and tested in a Langendorff system.

Authors:  Yan Li; Mones Abu-Asab; Junwu Su; Ping Qiu; Jing Feng; Lernik Ohanjanian; Hanish Sampath Kumar; Yvonne Fitz; Peter Q Eichacker; Xizhong Cui
Journal:  Am J Physiol Heart Circ Physiol       Date:  2015-04-10       Impact factor: 4.733

3.  Anthrax edema toxin has cAMP-mediated stimulatory effects and high-dose lethal toxin has depressant effects in an isolated perfused rat heart model.

Authors:  Caitlin W Hicks; Yan Li; Shu Okugawa; Steven B Solomon; Mahtab Moayeri; Stephen H Leppla; Ajana Mohanty; G Mani Subramanian; Thi S Mignone; Yvonne Fitz; Xizhong Cui; Peter Q Eichacker
Journal:  Am J Physiol Heart Circ Physiol       Date:  2011-01-07       Impact factor: 4.733

4.  An anthrax subunit vaccine candidate based on protective regions of Bacillus anthracis protective antigen and lethal factor.

Authors:  Les W Baillie; Theresa B Huwar; Stephen Moore; Gabriela Mellado-Sanchez; Liliana Rodriguez; Brendan N Neeson; Helen C Flick-Smith; Dominic C Jenner; Helen S Atkins; Rebecca J Ingram; Danny M Altmann; James P Nataro; Marcela F Pasetti
Journal:  Vaccine       Date:  2010-08-04       Impact factor: 3.641

5.  Anthrax lethal and edema toxins produce different patterns of cardiovascular and renal dysfunction and synergistically decrease survival in canines.

Authors:  Daniel A Sweeney; Xizhong Cui; Steven B Solomon; David A Vitberg; Thi S Migone; Dara Scher; Robert L Danner; Charles Natanson; G Mani Subramanian; Peter Q Eichacker
Journal:  J Infect Dis       Date:  2010-11-10       Impact factor: 5.226

6.  Cloning, expression and purification of binding domains of lethal factor and protective antigen of Bacillus anthracis in Escherichia coli and evaluation of their related murine antibody.

Authors:  Mehdi Rezaee; Hossein Honari; Mohammad Reza Ashrafi Kooshk
Journal:  Mol Biol Rep       Date:  2014-01-16       Impact factor: 2.316

7.  Nitric oxide production contributes to Bacillus anthracis edema toxin-associated arterial hypotension and lethality: ex vivo and in vivo studies in the rat.

Authors:  Yan Li; Xizhong Cui; Wanying Xu; Lernik Ohanjanian; Hanish Sampath-Kumar; Dante Suffredini; Mahtab Moayeri; Stephen Leppla; Yvonne Fitz; Peter Q Eichacker
Journal:  Am J Physiol Heart Circ Physiol       Date:  2016-07-22       Impact factor: 4.733

8.  Bacillus anthracis cell wall peptidoglycan but not lethal or edema toxins produces changes consistent with disseminated intravascular coagulation in a rat model.

Authors:  Ping Qiu; Yan Li; Joseph Shiloach; Xizhong Cui; Junfeng Sun; Loc Trinh; Joanna Kubler-Kielb; Evgeny Vinogradov; Haresh Mani; Mariam Al-Hamad; Yvonne Fitz; Peter Q Eichacker
Journal:  J Infect Dis       Date:  2013-06-03       Impact factor: 5.226

9.  Anthrax lethal factor as an immune target in humans and transgenic mice and the impact of HLA polymorphism on CD4+ T cell immunity.

Authors:  Stephanie Ascough; Rebecca J Ingram; Karen K Chu; Catherine J Reynolds; Julie A Musson; Mehmet Doganay; Gökhan Metan; Yusuf Ozkul; Les Baillie; Shiranee Sriskandan; Stephen J Moore; Theresa B Gallagher; Hugh Dyson; E Diane Williamson; John H Robinson; Bernard Maillere; Rosemary J Boyton; Daniel M Altmann
Journal:  PLoS Pathog       Date:  2014-05-01       Impact factor: 6.823

10.  Bacillus anthracis protective antigen kinetics in inhalation spore-challenged untreated or levofloxacin/ raxibacumab-treated New Zealand white rabbits.

Authors:  Alfred Corey; Thi-Sau Migone; Sally Bolmer; Michele Fiscella; Chris Ward; Cecil Chen; Gabriel Meister
Journal:  Toxins (Basel)       Date:  2013-01-14       Impact factor: 4.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.